Scholar Rock Holding Corp (SRRK)
15.10
+0.14
(+0.97%)
USD |
NASDAQ |
May 02, 16:00
15.10
0.00 (0.00%)
After-Hours: 20:00
Scholar Rock 1 Year Total Returns (Daily): 124.6% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | 124.6% |
April 30, 2024 | 129.2% |
April 29, 2024 | 132.7% |
April 26, 2024 | 102.4% |
April 25, 2024 | 88.39% |
April 24, 2024 | 91.96% |
April 23, 2024 | 93.33% |
April 22, 2024 | 83.01% |
April 19, 2024 | 96.45% |
April 18, 2024 | 93.75% |
April 17, 2024 | 72.54% |
April 16, 2024 | 74.78% |
April 15, 2024 | 66.42% |
April 12, 2024 | 68.34% |
April 11, 2024 | 76.46% |
April 10, 2024 | 74.38% |
April 09, 2024 | 88.79% |
April 08, 2024 | 84.71% |
April 05, 2024 | 88.10% |
April 04, 2024 | 78.22% |
April 03, 2024 | 80.45% |
April 02, 2024 | 96.50% |
April 01, 2024 | 109.9% |
March 28, 2024 | 141.5% |
March 27, 2024 | 92.88% |
Date | Value |
---|---|
March 26, 2024 | 92.06% |
March 25, 2024 | 105.0% |
March 22, 2024 | 79.13% |
March 21, 2024 | 83.37% |
March 20, 2024 | 80.18% |
March 19, 2024 | 61.17% |
March 18, 2024 | 40.43% |
March 15, 2024 | 39.88% |
March 14, 2024 | 43.63% |
March 13, 2024 | 72.06% |
March 12, 2024 | 81.93% |
March 11, 2024 | 78.31% |
March 08, 2024 | 70.14% |
March 07, 2024 | 61.49% |
March 06, 2024 | 75.94% |
March 05, 2024 | 75.78% |
March 04, 2024 | 70.67% |
March 01, 2024 | 82.96% |
February 29, 2024 | 80.65% |
February 28, 2024 | 95.57% |
February 27, 2024 | 100.5% |
February 26, 2024 | 88.81% |
February 23, 2024 | 77.07% |
February 22, 2024 | 71.38% |
February 21, 2024 | 59.53% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-84.66%
Minimum
Jun 21 2022
529.9%
Maximum
Jan 25 2021
27.38%
Average
-11.38%
Median
Mar 13 2020
1 Year Total Returns (Daily) Benchmarks
Regeneron Pharmaceuticals Inc | 11.94% |
Ocular Therapeutix Inc | -18.61% |
Alpine Immune Sciences Inc | 762.5% |
Keros Therapeutics Inc | 25.29% |
X4 Pharmaceuticals Inc | -29.94% |